Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...

BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $58 from $50 and keeps a Buy rating on the shares. The firm believes ...

Cipher Mining (NASDAQ:CIFR – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They ...

BTIG Research has recently reduced Beyond Air Inc (XAIR) stock to Neutral rating, as announced on June 25, 2024, according to Finviz. Earlier, on July 28, 2023, Piper Sandler had initiated the stock ...

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.27 which represents a decrease of $-0.01 or -3.57% from the prior close of $0.28. The stock opened at $0.28 and ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

Fulton Bank N.A. reduced its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.3% in the 4th quarter, ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Energy is the star sector of the S&P 500 Index in the early days of 2025, shaking off two consecutive years when it was a market laggard, and gaining despite Wall Street’s dim outlook for oil and gas ...

Stocks recovered from early losses Wednesday as strong demand for the Treasury’s $22 billion 30-year T-bond auction knocked T-note yields down from early highs, sparking short covering in stocks. ...